We are live on ! Find out more
DCPH

Deciphera Pharmaceuticals, Inc. Common Stock
DCPH

Delisted

DCPH was delisted on the 10th of June, 2024.

Back to rankings

1 hedge funds and large institutions have $759K invested in Deciphera Pharmaceuticals, Inc. Common Stock in 2024 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 174 closing their positions.

New
Increased
Maintained
Reduced
Closed

99% less funds holding

Funds holding: 177 → 1 (-176)

100% less capital invested

Capital invested by funds: $944M → $759K (-$943M)

100% less funds holding in top 10

Funds holding in top 10: 3 → 0 (-3)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 174

Holders
1
Holders Change
-176
Holders Change %
-99.44%
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
174
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$94.3M
2
AC
Armistice Capital
New York
-$92.8M
3
RG
Redmile Group
California
-$83.3M
4
DM
Deerfield Management
New York
-$80.7M
5
Vanguard Group
Vanguard Group
Pennsylvania
-$71.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
NYLIM
101
New York Life Investment Management
New York
– -$378K -24,061 Closed
Envestnet Asset Management
102
Envestnet Asset Management
Illinois
– -$375K -23,832 Closed
New York State Common Retirement Fund
103
New York State Common Retirement Fund
New York
– -$373K -23,724 Closed
EGM
104
Engineers Gate Manager
New York
– -$368K -23,377 Closed
Nisa Investment Advisors
105
Nisa Investment Advisors
Missouri
– -$362K -23,002 Closed
Capstone Investment Advisors
106
Capstone Investment Advisors
New York
– -$353K -22,421 Closed
Allspring Global Investments
107
Allspring Global Investments
North Carolina
– -$330K -20,990 Closed
YIH
108
Y-Intercept (HK)
Hong Kong
– -$320K -20,355 Closed
Fidelity Investments
109
Fidelity Investments
Massachusetts
– -$317K -20,178 Closed
BHCM
110
Brevan Howard Capital Management
Jersey
– -$295K -18,785 Closed
NIM
111
NEOS Investment Management
Connecticut
– -$293K -18,633 Closed
Los Angeles Capital Management
112
Los Angeles Capital Management
California
– -$291K -18,494 Closed
Wells Fargo
113
Wells Fargo
California
– -$282K -17,910 Closed
ETC
114
Exchange Traded Concepts
Oklahoma
– -$282K -17,909 Closed
EDRIA
115
Edmonds Duncan Registered Investment Advisors
Kansas
– -$279K -17,747 Closed
CIC
116
Cornercap Investment Counsel
Georgia
– -$262K -16,673 Closed
State Board of Administration of Florida Retirement System
117
State Board of Administration of Florida Retirement System
Florida
– -$257K -16,620 Closed
Principal Financial Group
118
Principal Financial Group
Iowa
– -$256K -16,303 Closed
CUAMC
119
China Universal Asset Management Company
China
– -$244K -15,513 Closed
T. Rowe Price Associates
120
T. Rowe Price Associates
Maryland
– -$242K -15,355 Closed
ProShare Advisors
121
ProShare Advisors
Maryland
– -$240K -15,265 Closed
Jane Street
122
Jane Street
New York
– -$232K -14,779 Closed
DTL
123
Dynamic Technology Lab
Singapore
– -$224K -14,257 Closed
Zurich Cantonal Bank
124
Zurich Cantonal Bank
Switzerland
– -$209K -13,266 Closed
A
125
AlphaQuest
New York
– -$207K -13,145 Closed
3 4
5
6 7

DCPH Hedge Fund Activity: Q2 2024 in Review

1 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) for Q2 2024, worth a combined $759K — down 100% from $944M a quarter earlier.

Sellers outnumbered buyers: 174 funds closed out of DCPH and 0 opened new positions — a net loss of 174 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was BlackRock, exiting entirely with an estimated $94.3M sold.

  • 1 institutional investor held Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) as of Q2 2024, down from 177 in Q1 2024.
  • Funds reported $759K of Deciphera Pharmaceuticals, Inc. Common Stock stock for Q2 2024, down 100% quarter-over-quarter.
  • 0 funds opened new Deciphera Pharmaceuticals, Inc. Common Stock positions in Q2 2024 and 174 closed out, a net change of -174 holders.
  • The largest Deciphera Pharmaceuticals, Inc. Common Stock seller in Q2 2024 was BlackRock, an estimated $94.3M sold.

Based on aggregated 13F filings for Q2 2024.